In the morning of August 1, 2017, Professor Ming-Wei Wang, Director of the National Center for Drug Screening/Chinese National Compound Library and Dean, School of Pharmacy, Fudan University, visited Sorrento Therapeutics, Inc. located at San Diego, California (U.S.A.). He was warmly received by Drs. Henry (Hongjun) Ji, an alumnus of Fudan University, a renowned biotechnology entrepreneur and Chief Executive Officer of the company (NASDAQ: SRNE) and Hui Li (Director of Business Development). Professor Wang joined their discussion with Mr. Richard Serbin, a well-known American biopharmaceutical technologist and partner of Platform Health Ventures (New York， USA) relative to new trends in investment in this area.